TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive New Firm Steps Onto Texas Battleground for Control Over Office-Based Oncology November 22, 1996
TCL Archive Merger Of Centers, Control Programs An Option, Upton Says; ACS To Fund New Prevention Centers February 2, 1979